Jazz Pharmaceuticals plc

BRSE:J7Z Stock Report

Market Cap: CHF 5.7b

Jazz Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BRSE:J7Z Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Dec 24SellCHF 5,755Patricia CarrIndividual53CHF 108.58
08 Nov 24SellCHF 399,225Neena PatilIndividual3,700CHF 107.90
06 Sep 24SellCHF 128,492Mary HendersonIndividual1,410CHF 91.13
07 Jun 24SellCHF 15,897Patricia CarrIndividual163CHF 97.53
03 May 24SellCHF 495,974Neena PatilIndividual5,000CHF 99.19
07 Mar 24SellCHF 384,975Patricia CarrIndividual3,704CHF 106.11
01 Mar 24BuyCHF 1,270,870Philip JohnsonIndividual12,000CHF 105.91

Insider Trading Volume

Insider Buying: J7Z insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of J7Z?
Owner TypeNumber of SharesOwnership Percentage
State or Government58,1280.0922%
General Public1,170,7031.86%
Individual Insiders1,726,0512.74%
Institutions60,107,47495.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
BlackRock, Inc.
7,069,920CHF 641.3m0.2%0.01%
10.2%
The Vanguard Group, Inc.
6,448,689CHF 585.0m1.33%0.01%
3.9%
State Street Global Advisors, Inc.
2,462,135CHF 223.3m1.69%0.01%
3.78%
LSV Asset Management
2,380,858CHF 216.0m1.61%0.47%
2.27%
Polaris Capital Management, LLC
1,432,660CHF 130.0m13%1.99%
2.26%
Capital Research and Management Company
1,427,860CHF 129.5m0%0.01%
2.18%
JP Morgan Asset Management
1,372,377CHF 124.5m4.21%0.02%
2.17%
Columbia Management Investment Advisers, LLC
1,368,949CHF 124.2m4.28%0.03%
2.05%
Pacer Advisors, Inc.
1,293,726CHF 117.4m26.4%0.33%
1.85%
Seamus Mulligan
1,169,300CHF 106.1m0%no data
1.85%
Renaissance Technologies LLC
1,165,568CHF 105.7m-5.36%0.19%
1.82%
Camber Capital Management LP
1,150,000CHF 104.3m70.4%4.35%
1.76%
Geode Capital Management, LLC
1,107,310CHF 100.4m5.52%0.01%
1.74%
Vestal Point Capital, LP
1,100,000CHF 99.8m51.7%10.2%
1.72%
Fuller & Thaler Asset Management, Inc.
1,085,140CHF 98.4m0%0.52%
1.61%
EcoR1 Capital, LLC
1,013,952CHF 92.0m0%3.31%
1.6%
Swedbank Robur Fonder AB
1,009,810CHF 91.6m0%0.07%
1.47%
FMR LLC
924,326CHF 83.8m-22.7%0.01%
1.44%
Franklin Resources, Inc.
906,175CHF 82.2m3.57%0.03%
1.32%
The Baupost Group, L.L.C.
833,696CHF 75.6m0%2.34%
1.31%
Dimensional Fund Advisors LP
823,649CHF 74.7m7.55%0.01%
1.13%
AQR Capital Management, LLC
710,513CHF 64.5m134%0.12%
0.93%
Avidity Partners Management, L.P.
584,000CHF 53.0m19.4%2.49%
0.88%
Thompson, Siegel & Walmsley LLC
552,573CHF 50.1m56.7%0.64%
0.87%
BNY Asset Management
549,792CHF 49.9m-3.27%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/07 14:56
End of Day Share Price 2024/04/09 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jazz Pharmaceuticals plc is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Ishan MajumdarBaptista Research
Richard SilverBarclays